Cargando…

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer

IMPORTANCE: Steroid hormone receptors, including estrogen receptor (ER) and progesterone receptor (PR), are crucial biomarkers in breast cancer (BC). However, limited data are available regarding single hormone receptor–positive (ER-positive/PR-negative and ER-negative/PR-positive) subtypes, renderi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yunhai, Yang, Dejuan, Yin, Xuedong, Zhang, Xiang, Huang, Jiefeng, Wu, Yusheng, Wang, Mengxue, Yi, Zhiying, Li, Hongyuan, Li, Hongzhong, Ren, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991239/ https://www.ncbi.nlm.nih.gov/pubmed/31899528 http://dx.doi.org/10.1001/jamanetworkopen.2019.18160

Ejemplares similares

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
por: Li, Yunhai, et al.
Publicado: (2019)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Yunhai, et al.
Publicado: (2021)

Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
por: Li, Yunhai, et al.
Publicado: (2018)

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer
por: Wang, Long, et al.
Publicado: (2021)

Clinicopathological Features of Breast Cancer in Relation to Exposure of Cycling Reproductive Hormones: A Multicenter Retrospective Study of 14 731 Patients Diagnosed with Invasive Breast Cancer
por: Sun, Jiazheng, et al.
Publicado: (2022)

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers
por: Li, Yunhai, et al.
Publicado: (2016)

Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study
por: Wang, Jing, et al.
Publicado: (2021)

Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells
por: Li, Hongzhong, et al.
Publicado: (2015)

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
por: Wu, Yushen, et al.
Publicado: (2022)

Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer
por: Wang, Mengxue, et al.
Publicado: (2020)

Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation
por: Li, Xia, et al.
Publicado: (2018)

Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth
por: Yi, Ziying, et al.
Publicado: (2020)

Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression
por: Yang, Dejuan, et al.
Publicado: (2018)

Clinicopathological characteristics and survival outcomes in patients with angiosarcoma of breast
por: Li, Junfeng, et al.
Publicado: (2023)

Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
por: Gan, Lu, et al.
Publicado: (2016)

ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth and endocrine therapy resistance
por: Huang, Jiefeng, et al.
Publicado: (2022)

Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor–Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis
por: Li, Jinming, et al.
Publicado: (2020)

Prevalence of Thyroid Nodules in China: A Health Examination Cohort-Based Study
por: Li, Yunhai, et al.
Publicado: (2021)

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)

Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer
por: Li, Yujing, et al.
Publicado: (2019)

ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer
por: Liu, Jiazhou, et al.
Publicado: (2021)

Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer
por: Kim, Hakyoung, et al.
Publicado: (2023)

Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women With Breast Cancer
por: Branigan, Gregory L., et al.
Publicado: (2020)

Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database
por: Peiffer, Daniel S., et al.
Publicado: (2023)

The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients
por: Qi, Wanwan, et al.
Publicado: (2020)

Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients
por: Feng, Fan, et al.
Publicado: (2018)

RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway
por: Zhang, Xiang, et al.
Publicado: (2013)

Neighborhood Disadvantage and Breast Cancer–Specific Survival
por: Goel, Neha, et al.
Publicado: (2023)

Survival Outcomes in Patients With Hormone Receptor–Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
por: Mouabbi, Jason A., et al.
Publicado: (2023)

Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia
por: Chang, Wei-Ting, et al.
Publicado: (2023)

Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China
por: Xue, Cong, et al.
Publicado: (2012)

Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
por: Yuan, Hongfan, et al.
Publicado: (2019)

Patient Perspectives on Treatment Options for Older Women With Hormone Receptor–Positive Breast Cancer: A Qualitative Study
por: Wang, Ton, et al.
Publicado: (2020)

Clinicopathological characteristics, evolution, treatment pattern and outcomes of hormone-receptor-positive/HER2-low metastatic breast cancer
por: You, Shuhui, et al.
Publicado: (2023)

Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden
por: Johansson, Annelie, et al.
Publicado: (2021)

Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
por: Li, Shuting, et al.
Publicado: (2019)

Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF‐κB signaling
por: Xu, Hongying, et al.
Publicado: (2017)

Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
por: Shao, Qing, et al.
Publicado: (2017)

Vessel size as a marker of survival in estrogen receptor positive breast cancer
por: Milosevic, Vladan, et al.
Publicado: (2023)

The implication from RAS/RAF/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer
por: Huang, Jianbo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u9i4kri8f21c6vhn62jnigiaj8